Mixed adenoneuroendocrine carcinoma (MANEC) is a rare tumor of the gastrointestinal tract that has both exocrine and neuroendocrine components. There are only 5 case reports about this combined tumor in the small bowel, arose in a background of long-standing Crohn's disease. Here, we report a case of small bowel MANEC in a 54-year-old male with Crohn's disease, who presented a heterogeneous enhancing, asymmetric small bowel wall thickening with small bowel obstruction and had a difficulty in differential diagnosis before surgery.
INTRODUCTION
Mixed adenoneuroendocrine carcinoma (MANEC) was classified by the World Health Organization (WHO) in 2010 referring to a neoplasm with dual adenocarcinomatous and neuroendocrine differentiation. It is very rare malignancy of gastrointestinal tract and several cases were reported in the pancreas, colon, gallbladder, biliary tract, stomach, ampulla, cecum and esophagogastric junction, in order of frequency (1) . But, there are only few reports in the small bowel, especially in Crohn's disease patient. Here, we report a case of MANEC of the small bowel in Crohn's disease patient.
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Mixed Adenoneuroendocrine Carcinoma of the Small Bowel in Crohn's Disease Patient
CASE REPORT
A 54-year-old male visited to our emergency room for abdominal pain and distension for 3 weeks. He had the diagnosis of Crohn's disease for 30 years, and the surgical history of the segmental resection of ileum for bowel obstruction and primary repair for enteric fistula.
Bowel sound was absent on physical examination, and simple radiograph showed ileus ( Fig.   1A ). On initial laboratory examination, white blood cell count was 14080/μL with neutrophilia of 85% and the C-reactive protein was elevated to 5.3 mg/dL. A dynamic phase contrast-enhanced abdominopelvic computed tomography (CT) was performed. CT examination revealed an asymmetric segmental wall thickening of jejunum ( Fig.   1B , C). The thickened bowel showed heterogeneous enhancement with loss of normal layered pattern, and mesenteric fat stranding. Mild proximal small bowel dilatation also showed. And there were multiple enlarged mesenteric lymph nodes with central low density We performed a ultrasonography-guided core needle biopsy on hepatic nodule and the initial pathology was an adenocarcinoma, probably metastasis from the small bowel carcinoma.
The patient was treated with conservative therapy and discharged for further chemotherapy of the cancer. Crohn's disease is associated with a 14.9 fold incidence of neuroendocrine tumor compare to incidental neuroendocrine tumor found in appendectomy specimen from healthy people.
However, as most neuroendocrine tumors are found incidentally during surgery their true incidence in Crohn's disease is unknown (4, 5) .
It is unclear whether there is a connection between the pathogenesis of Crohn's disease and carcinoid tumor. Some carcinoid tumors are found in colonic segments that are free from inflammation. This finding suggests that the development of neuroendocrine tumor in Crohn's disease may result from local inflammation and/or may be secondary to distant secretion of mediators (4, 5) .
Simultaneous presence of neuroendocrine tumor and Crohn's disease is extremely rare, with 52 reported cases in the literature (5) . So, it is very difficult to differential diagnose between benign stricture of Crohn's disease, Crohn's disease-related adenocarcinoma and neuroendocrine tumor in preoperatively (8, 9) .
The optimal management of MANEC is largely unknown, due to its rarity. But, the more In this report, we report a MANEC of the small bowel in Crohn's disease patient. Because of its rare incidence and non-specific image finding, it is difficult to diagnose MANEC before surgery. However, MANEC has different treatment and prognosis with other diseases. Therefore, we should understand the disease entity of MANEC so that appropriate treatment can
